Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Osteoporosis
Interventions: OTHER: biologic sample preservation procedure|PROCEDURE: dual x-ray absorptometry
Sponsor: NCIC Clinical Trials Group